These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Drug therapy of acute myocardial infarction without cardiogenic shock and thrombolytic therapy excluded]. Roul G; Bareiss P; Mossard JM; Sacrez A Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):763-71. PubMed ID: 1356327 [TBL] [Abstract][Full Text] [Related]
10. Prevention of myocardial reinfarction. Recommendations based on results of drug trials. Flaker GC; Singh VN Postgrad Med; 1993 Nov; 94(6):94-8, 102-4. PubMed ID: 7901845 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis. Becker RC; Gore JM Am J Cardiol; 1991 Jan; 67(3):25A-31A. PubMed ID: 1671315 [TBL] [Abstract][Full Text] [Related]
12. [Cardioprotection with drugs. 1: Coronary heart disease]. Michel D Fortschr Med; 1990 Jan; 108(3):40-4. PubMed ID: 1968878 [TBL] [Abstract][Full Text] [Related]
13. Management of the older person after MI. Aronow WS Compr Ther; 1997 Apr; 23(4):259-68. PubMed ID: 9167918 [No Abstract] [Full Text] [Related]
14. [Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction]. Coumel P Arch Mal Coeur Vaiss; 1990 Sep; 83(10):1497-9. PubMed ID: 1978650 [No Abstract] [Full Text] [Related]
15. Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction. Gutstein DE; Fuster V Clin Cardiol; 1998 Mar; 21(3):161-8. PubMed ID: 9541759 [TBL] [Abstract][Full Text] [Related]
16. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases]. Stetsenko AE; Kassil' VL; Ushakova TI Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304 [TBL] [Abstract][Full Text] [Related]
17. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes]. Birdane A; Ata N Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies. Avezum A; Pais P; Flather MD; Anand S; Yusuf S Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849 [No Abstract] [Full Text] [Related]
19. Medical therapy of acute myocardial infarction: Part II. The role of adjunctive medical therapy. Jafri SM; Borzak S J Intensive Care Med; 1995; 10(3):109-16. PubMed ID: 10155176 [TBL] [Abstract][Full Text] [Related]
20. Coronary thrombolysis: adjuvant medical therapy. Theroux P; Roy L Can J Cardiol; 1993; 9(6):524-8. PubMed ID: 8221351 [No Abstract] [Full Text] [Related] [Next] [New Search]